Gene Therapy

Gene Therapy Solutions

We provide innovative payer solutions to help finance and manage the risk of new gene therapies

Explore our solutions to help address the growing gene therapy pipeline


Reinsurance pool product for health plans that covers the cost of gene therapy ingredients to protect against large, catastrophic claims, and offers back-end management services

Gene Therapy Stop Loss

A gene-therapy-only stop loss product designed to protect large, self-insured employers from the frequency and severity of these one-time treatments

Cost Containment Solutions

Access to a variety of partnerships with specialty vendors and service providers that support clinical intervention and cost-saving initiatives to manage exposure to high-cost claims

Learn more

For more information about innovative gene therapy products, contact your BCS representative.

BCS Financial Leading the Way with New Gene Therapy Reinsurance Solutions

November 28, 2023
New solutions aim to improve access to growing gene therapy pipeline by financing and mitigating health payer risk CHICAGO, Nov. 28, 2023 /PRNewswire/ — BCS Financial has expanded its stop loss and reinsurance offerings to include new payer solutions in response to the rapidly growing gene therapy pipeline. With more than 20 therapies expected to hit the…
Read More